Company
Every investor coverage indicates participated in a round Stanford Biodesign ENT Innovation program raised.
Companies Stanford Biodesign ENT Innovation program acquired or merged with, per published coverage. Buying a company is not investing in one: nothing here counts in the deals column.
Stories naming Stanford Biodesign ENT Innovation program. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Two medical startups have received a $3 million federal CRC-P grant to build RhinoMAP, an AI tool giving clinicians earlier reads on whether respiratory treatments are working, with university and clinical partners.
Melbourne biotech Diag-Nose.io raised a seed round led by Breakthrough Victoria for its AI respiratory diagnostic, backed by physicians, funds and executives; one investor joins its board.